Our Story
From vision to veterinary medical innovation
Birth of the vision
Idea: Regenerative medicine with stem cells should be universally accessible to all people and animals. A treatment method characterized by simplicity and universal availability.
Prototyping & patent application
Start of product development & first prototypes. Worldwide PCT patent application for initial protection of the idea.
Founding & building high-tech production
Founding of RegMed. Focus on promoting equine health. Building a unique production process with a 3D printer for highly compact filter systems in a clean room.
Clinical validation
Successful treatments at partner clinic.
RegMed Vet for horses
Market launch of RegMed Vet – the first patented stem cell therapy for horses, applicable directly in practice.
Vision: Regenerative medicine for everyone
Evolution of veterinary & human medicine – stem cell therapy universally accessible to humans and animals.
Who is RegMed?
The people behind the innovation
RegMed is the fusion of innovation and high-tech with medicine. Regenerative medicine for everyone!
Our Story
Who is RegMed?
Tom Smets
Chief Executive Officer
Prof. Dr. Ing. Heiner Smets
Chief Technology Officer
Professor of Management & Technology
Cedric Smets
Chief Medical Officer
Orthopedist & Trauma Surgeon
Our Vision
Our vision is to make regenerative medicine available to everyone and every animal around the world by 2030. We want to bring medical care for humans and animals into the 21st century.
Tom Smets
CEO
“With RegMed, we make regenerative therapies available where they are needed – for humans and animals.”